BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $82.56 million versus the consensus estimate of $78.22 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.